Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laparoscopy | 28 | 2026 | 800 | 4.980 |
Why?
|
| Hernia, Inguinal | 15 | 2024 | 75 | 3.600 |
Why?
|
| Herniorrhaphy | 16 | 2025 | 95 | 3.360 |
Why?
|
| Simulation Training | 8 | 2026 | 118 | 2.220 |
Why?
|
| Peritoneal Dialysis | 4 | 2023 | 35 | 2.180 |
Why?
|
| Kidney Failure, Chronic | 5 | 2023 | 451 | 1.560 |
Why?
|
| Catheters, Indwelling | 4 | 2023 | 102 | 1.400 |
Why?
|
| Robotic Surgical Procedures | 4 | 2026 | 425 | 1.290 |
Why?
|
| Bariatric Surgery | 6 | 2026 | 218 | 1.280 |
Why?
|
| Quality of Life | 16 | 2026 | 1904 | 1.220 |
Why?
|
| Catheterization | 4 | 2023 | 220 | 1.150 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 3 | 2015 | 8 | 1.110 |
Why?
|
| Internship and Residency | 6 | 2026 | 1132 | 1.110 |
Why?
|
| Clinical Competence | 12 | 2026 | 873 | 1.060 |
Why?
|
| Recurrence | 7 | 2025 | 1274 | 1.040 |
Why?
|
| Obesity | 4 | 2025 | 1079 | 1.020 |
Why?
|
| Hernia, Abdominal | 3 | 2021 | 14 | 0.960 |
Why?
|
| Curriculum | 9 | 2026 | 643 | 0.930 |
Why?
|
| Pelvic Floor Disorders | 1 | 2026 | 62 | 0.890 |
Why?
|
| Surgical Mesh | 8 | 2023 | 126 | 0.890 |
Why?
|
| Peritoneum | 3 | 2023 | 52 | 0.850 |
Why?
|
| Edema | 2 | 2015 | 68 | 0.830 |
Why?
|
| General Surgery | 2 | 2026 | 271 | 0.820 |
Why?
|
| Education, Medical, Graduate | 2 | 2026 | 455 | 0.800 |
Why?
|
| Abdominal Wall | 3 | 2025 | 35 | 0.790 |
Why?
|
| Obesity, Morbid | 8 | 2026 | 255 | 0.730 |
Why?
|
| Gastroesophageal Reflux | 5 | 2022 | 131 | 0.680 |
Why?
|
| Cholecystectomy, Laparoscopic | 4 | 2022 | 53 | 0.640 |
Why?
|
| Rectus Abdominis | 2 | 2017 | 41 | 0.600 |
Why?
|
| Gastric Bypass | 4 | 2026 | 121 | 0.590 |
Why?
|
| Retrospective Studies | 25 | 2026 | 11104 | 0.560 |
Why?
|
| Treatment Outcome | 24 | 2025 | 9806 | 0.510 |
Why?
|
| Humans | 64 | 2026 | 98799 | 0.510 |
Why?
|
| Surgeons | 4 | 2022 | 336 | 0.490 |
Why?
|
| Fundoplication | 7 | 2022 | 78 | 0.490 |
Why?
|
| Pyloromyotomy | 3 | 2021 | 14 | 0.480 |
Why?
|
| Hernia, Hiatal | 3 | 2023 | 38 | 0.480 |
Why?
|
| Specialties, Surgical | 1 | 2017 | 90 | 0.470 |
Why?
|
| Omentum | 1 | 2016 | 69 | 0.470 |
Why?
|
| Myotomy | 3 | 2021 | 31 | 0.470 |
Why?
|
| Genitalia, Male | 1 | 2015 | 24 | 0.460 |
Why?
|
| Genitalia | 1 | 2015 | 18 | 0.460 |
Why?
|
| Genitalia, Female | 1 | 2015 | 27 | 0.460 |
Why?
|
| Esophageal Achalasia | 3 | 2020 | 61 | 0.440 |
Why?
|
| Male | 36 | 2026 | 47475 | 0.430 |
Why?
|
| Natural Orifice Endoscopic Surgery | 3 | 2020 | 44 | 0.420 |
Why?
|
| Female | 33 | 2026 | 51997 | 0.410 |
Why?
|
| Aged | 21 | 2025 | 21986 | 0.390 |
Why?
|
| Scrotum | 1 | 2013 | 15 | 0.390 |
Why?
|
| Body Mass Index | 4 | 2025 | 869 | 0.380 |
Why?
|
| Weight Loss | 4 | 2026 | 247 | 0.370 |
Why?
|
| Hernia, Ventral | 3 | 2025 | 31 | 0.370 |
Why?
|
| Esophageal Motility Disorders | 2 | 2022 | 17 | 0.340 |
Why?
|
| Middle Aged | 26 | 2025 | 29642 | 0.340 |
Why?
|
| Deglutition Disorders | 2 | 2023 | 126 | 0.340 |
Why?
|
| Adult | 22 | 2024 | 29698 | 0.340 |
Why?
|
| Hernia, Umbilical | 2 | 2021 | 13 | 0.320 |
Why?
|
| Foreign Bodies | 2 | 2022 | 62 | 0.270 |
Why?
|
| Stomach | 3 | 2016 | 112 | 0.260 |
Why?
|
| Reoperation | 3 | 2021 | 730 | 0.250 |
Why?
|
| Catheterization, Peripheral | 1 | 2007 | 63 | 0.240 |
Why?
|
| Suture Techniques | 3 | 2016 | 142 | 0.240 |
Why?
|
| Prospective Studies | 7 | 2026 | 4837 | 0.240 |
Why?
|
| Esophageal Sphincter, Lower | 3 | 2021 | 32 | 0.230 |
Why?
|
| Operative Time | 2 | 2024 | 178 | 0.230 |
Why?
|
| Abdominal Muscles | 1 | 2025 | 26 | 0.230 |
Why?
|
| Fecal Incontinence | 1 | 2026 | 62 | 0.230 |
Why?
|
| Incisional Hernia | 3 | 2021 | 20 | 0.230 |
Why?
|
| Follow-Up Studies | 9 | 2019 | 4049 | 0.220 |
Why?
|
| Postoperative Complications | 4 | 2020 | 2719 | 0.210 |
Why?
|
| Endoscopy, Gastrointestinal | 3 | 2022 | 171 | 0.200 |
Why?
|
| Barrett Esophagus | 2 | 2015 | 94 | 0.200 |
Why?
|
| Urinary Incontinence | 1 | 2026 | 226 | 0.200 |
Why?
|
| Physicians | 2 | 2021 | 687 | 0.200 |
Why?
|
| Laparotomy | 3 | 2019 | 65 | 0.200 |
Why?
|
| Surgical Wound Infection | 1 | 2025 | 252 | 0.190 |
Why?
|
| Pelvic Organ Prolapse | 1 | 2026 | 199 | 0.190 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2021 | 14 | 0.170 |
Why?
|
| Virtual Reality | 1 | 2022 | 40 | 0.170 |
Why?
|
| Safety | 1 | 2021 | 138 | 0.170 |
Why?
|
| Gastroparesis | 1 | 2021 | 17 | 0.170 |
Why?
|
| Computer Simulation | 5 | 2022 | 1152 | 0.160 |
Why?
|
| Esophagoplasty | 1 | 2020 | 9 | 0.160 |
Why?
|
| Biological Products | 1 | 2023 | 191 | 0.160 |
Why?
|
| Insufflation | 1 | 2020 | 12 | 0.160 |
Why?
|
| Esophagitis, Peptic | 1 | 2020 | 10 | 0.160 |
Why?
|
| Intraoperative Complications | 1 | 2021 | 195 | 0.160 |
Why?
|
| Electric Impedance | 4 | 2021 | 118 | 0.160 |
Why?
|
| Cholecystitis | 1 | 2020 | 17 | 0.150 |
Why?
|
| Cholelithiasis | 1 | 2020 | 36 | 0.150 |
Why?
|
| Cholecystectomy | 1 | 2020 | 29 | 0.150 |
Why?
|
| Diverticulitis | 1 | 2019 | 10 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2020 | 2680 | 0.150 |
Why?
|
| Jejunum | 2 | 2016 | 78 | 0.150 |
Why?
|
| Health Care Surveys | 1 | 2020 | 282 | 0.150 |
Why?
|
| Teaching | 1 | 2020 | 145 | 0.150 |
Why?
|
| Patient Care Management | 1 | 2019 | 29 | 0.150 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2021 | 153 | 0.140 |
Why?
|
| Perception | 1 | 2020 | 190 | 0.140 |
Why?
|
| Urinary Catheterization | 1 | 2018 | 40 | 0.140 |
Why?
|
| Physicians, Primary Care | 1 | 2020 | 108 | 0.140 |
Why?
|
| Common Bile Duct | 1 | 2017 | 19 | 0.130 |
Why?
|
| Self-Assessment | 1 | 2017 | 45 | 0.130 |
Why?
|
| Acute Disease | 2 | 2019 | 864 | 0.130 |
Why?
|
| Choledocholithiasis | 1 | 2017 | 14 | 0.130 |
Why?
|
| Chronic Pain | 1 | 2020 | 207 | 0.130 |
Why?
|
| Asymptomatic Diseases | 1 | 2017 | 48 | 0.130 |
Why?
|
| Prostatic Hyperplasia | 1 | 2018 | 105 | 0.130 |
Why?
|
| Self Concept | 1 | 2017 | 141 | 0.130 |
Why?
|
| Societies, Medical | 1 | 2021 | 687 | 0.120 |
Why?
|
| Hospitals, High-Volume | 1 | 2017 | 53 | 0.120 |
Why?
|
| Dexamethasone | 1 | 2018 | 318 | 0.120 |
Why?
|
| Patient Safety | 1 | 2019 | 237 | 0.120 |
Why?
|
| Equipment Safety | 1 | 2016 | 29 | 0.120 |
Why?
|
| Muscular Atrophy | 1 | 2017 | 49 | 0.120 |
Why?
|
| Pain Measurement | 3 | 2020 | 403 | 0.120 |
Why?
|
| Diagnostic Imaging | 1 | 2020 | 468 | 0.120 |
Why?
|
| Referral and Consultation | 1 | 2020 | 419 | 0.120 |
Why?
|
| Equipment Failure | 1 | 2016 | 120 | 0.120 |
Why?
|
| Weight Reduction Programs | 1 | 2016 | 14 | 0.120 |
Why?
|
| Hospitals, University | 1 | 2016 | 192 | 0.120 |
Why?
|
| Prostatectomy | 1 | 2019 | 491 | 0.120 |
Why?
|
| Esophagoscopy | 3 | 2020 | 91 | 0.110 |
Why?
|
| Risk Assessment | 3 | 2019 | 2604 | 0.110 |
Why?
|
| Gastroenterology | 1 | 2017 | 162 | 0.110 |
Why?
|
| Cohort Studies | 3 | 2019 | 3242 | 0.110 |
Why?
|
| Feasibility Studies | 1 | 2017 | 818 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 608 | 0.110 |
Why?
|
| Time Factors | 3 | 2021 | 5586 | 0.110 |
Why?
|
| Contraindications | 1 | 2014 | 66 | 0.110 |
Why?
|
| Child | 2 | 2023 | 7771 | 0.110 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 688 | 0.110 |
Why?
|
| Remission, Spontaneous | 1 | 2014 | 45 | 0.100 |
Why?
|
| Endoscopy | 3 | 2022 | 388 | 0.100 |
Why?
|
| Ultrasonography | 1 | 2015 | 722 | 0.090 |
Why?
|
| Databases, Factual | 3 | 2021 | 1102 | 0.080 |
Why?
|
| Esophagogastric Junction | 2 | 2021 | 36 | 0.080 |
Why?
|
| Swine | 2 | 2022 | 593 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 7461 | 0.080 |
Why?
|
| Elective Surgical Procedures | 2 | 2021 | 178 | 0.070 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2025 | 317 | 0.070 |
Why?
|
| Operating Rooms | 2 | 2022 | 151 | 0.070 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2022 | 337 | 0.070 |
Why?
|
| United States | 2 | 2021 | 8387 | 0.070 |
Why?
|
| Surveys and Questionnaires | 3 | 2021 | 3058 | 0.070 |
Why?
|
| Abdomen | 1 | 2007 | 121 | 0.060 |
Why?
|
| Recovery of Function | 2 | 2019 | 373 | 0.060 |
Why?
|
| Abdominal Pain | 1 | 2007 | 149 | 0.060 |
Why?
|
| Equipment Design | 1 | 2007 | 428 | 0.060 |
Why?
|
| Weight Gain | 2 | 2016 | 139 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 3622 | 0.050 |
Why?
|
| Preoperative Care | 2 | 2020 | 420 | 0.050 |
Why?
|
| Patient Selection | 3 | 2019 | 725 | 0.050 |
Why?
|
| Manometry | 1 | 2022 | 43 | 0.050 |
Why?
|
| Vitamin D | 2 | 2015 | 287 | 0.040 |
Why?
|
| Bile Ducts | 1 | 2021 | 62 | 0.040 |
Why?
|
| Esophageal Neoplasms | 2 | 2015 | 355 | 0.040 |
Why?
|
| Prognosis | 2 | 2020 | 4139 | 0.040 |
Why?
|
| Splenectomy | 1 | 2021 | 50 | 0.040 |
Why?
|
| Gastrectomy | 1 | 2022 | 75 | 0.040 |
Why?
|
| Hernia | 1 | 2021 | 21 | 0.040 |
Why?
|
| Pylorus | 1 | 2021 | 15 | 0.040 |
Why?
|
| Gastric Emptying | 1 | 2021 | 26 | 0.040 |
Why?
|
| United Kingdom | 1 | 2021 | 217 | 0.040 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 83 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2022 | 195 | 0.040 |
Why?
|
| Spleen | 1 | 2021 | 375 | 0.040 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2022 | 251 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2020 | 77 | 0.040 |
Why?
|
| Publishing | 1 | 2021 | 97 | 0.040 |
Why?
|
| Esophagus | 1 | 2020 | 113 | 0.040 |
Why?
|
| Disease Progression | 2 | 2015 | 1621 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 2021 | 169 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2022 | 263 | 0.040 |
Why?
|
| Wound Closure Techniques | 1 | 2019 | 15 | 0.040 |
Why?
|
| Device Removal | 1 | 2021 | 170 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 214 | 0.040 |
Why?
|
| Postoperative Care | 1 | 2020 | 239 | 0.040 |
Why?
|
| Evidence-Based Practice | 1 | 2019 | 54 | 0.040 |
Why?
|
| Urinary Retention | 1 | 2018 | 43 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2019 | 160 | 0.030 |
Why?
|
| Stents | 1 | 2022 | 442 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2019 | 90 | 0.030 |
Why?
|
| Disease Management | 1 | 2020 | 378 | 0.030 |
Why?
|
| Visual Analog Scale | 1 | 2017 | 18 | 0.030 |
Why?
|
| Adenocarcinoma | 2 | 2015 | 1215 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2021 | 538 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 909 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2020 | 385 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 1007 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 925 | 0.030 |
Why?
|
| Dilatation, Pathologic | 1 | 2016 | 47 | 0.030 |
Why?
|
| Surgical Stomas | 1 | 2016 | 22 | 0.030 |
Why?
|
| Atrophy | 1 | 2017 | 131 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2022 | 2556 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2018 | 371 | 0.030 |
Why?
|
| Granuloma | 1 | 1996 | 65 | 0.030 |
Why?
|
| Health Status Indicators | 1 | 2016 | 99 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2020 | 408 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2016 | 325 | 0.030 |
Why?
|
| Video Recording | 1 | 2016 | 217 | 0.030 |
Why?
|
| Proton Pump Inhibitors | 1 | 2015 | 36 | 0.030 |
Why?
|
| Coronary Disease | 1 | 1996 | 227 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 99 | 0.030 |
Why?
|
| Neoplasm Regression, Spontaneous | 1 | 2014 | 8 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2016 | 349 | 0.030 |
Why?
|
| Hospitalization | 1 | 2020 | 993 | 0.030 |
Why?
|
| Health Status | 1 | 2016 | 388 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 1996 | 234 | 0.020 |
Why?
|
| Bone Density Conservation Agents | 1 | 2014 | 54 | 0.020 |
Why?
|
| Pneumonectomy | 1 | 1996 | 222 | 0.020 |
Why?
|
| Risk Factors | 2 | 2015 | 6295 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 2025 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 1863 | 0.020 |
Why?
|
| Illinois | 1 | 2014 | 531 | 0.020 |
Why?
|
| Animals | 2 | 2022 | 29045 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 466 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 519 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2016 | 441 | 0.020 |
Why?
|
| Logistic Models | 1 | 2015 | 1276 | 0.020 |
Why?
|
| Sex Factors | 1 | 2014 | 1144 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 1798 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1976 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 483 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1996 | 2474 | 0.010 |
Why?
|
| Prevalence | 1 | 1996 | 1396 | 0.010 |
Why?
|